Eleven of the core BC genes already carry convincing epidemiological evidence for BC risk (binomial enrichment p = 1.47 × 10−3), among them four (ATM, BRCA2, CHEK2, PALB2) are currently interrogated by hereditary BC panels (Invitae, Myriad MyRisk, Table 3). The gene discussed is ATM; the disease is breast cancer.